EORTC-62092-22092-STBSG-ROG

Back to Clinical Trials Database

A phase III randomized study of preoperative radiotherapy plus surgery versus surgery alone for patients with Retroperitoneal sarcomas (RPS) - STRASS

Study documentation Publications

Trial Status	LT-FU ongoing
Dates	Date of activation: 16-Jan-2012 Date Step1 close: 11-Apr-2017
Data management at EORTC	Yes
Design	Phase 3 Randomized open label
Targeted Sample size	EORTC Groups: 256 - All Groups: 256
Treatment	Radiotherapy, Surgery
Study Staff	Sylvie Bonvalot (Study Coordinator) , Institut Curie- Hopital de Paris, PARIS CEDEX 05 Rick Haas (Study Coordinator) , The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis, Amsterdam Enrico Clementel (QART Manager) , EORTC Headquarters, Brussels Stephanie Kromar (Regulatory Affairs Manager) , EORTC Headquarters, Brussels Saskia Litiere (Statistician) , EORTC Headquarters, Brussels Sandrine Marreaud (Clinical Research Physician) , EORTC Headquarters, Brussels Axelle Nzokirantevye (Data Manager) , EORTC Headquarters, Brussels Sandrine Rivrain (Pharmacovigilance Manager) , EORTC Headquarters, Brussels Ionela Stanciu (Clinical Operations Manager) , EORTC Headquarters, Brussels
Type of cancer	Soft Tissue and Bone Sarcoma
Participating groups	EORTC Radiation Oncology Group EORTC Soft Tissue and Bone Sarcoma Group
Recruiting centers	CHU de Toulouse - Institut Claudius Regaud - IUCT oncopole (TOULOUSE CEDEX 9, France) Centre Hospitalier de l'Université de Montreal - Hopital Notre-Dame (Montreal, Canada) Centre Leon Berard (Lyon, France) Centro Di Riferimento Oncologico (Aviano, Italy) Dana-Farber Cancer Institute & Harvard Medical School (Boston, United States of America) Gustave Roussy (VILLEJUIF CEDEX, France) Herlev Hospital - University Copenhagen (Herlev, Denmark) Hospital Universitari Vall d’Hebron -Vall d'Hebron Institut Oncologia (Barcelona, Spain) Hospital Universitario San Carlos (Madrid, Spain) IRCCS - Fondazione Istituto Nazionale dei Tumori (Milano, Italy) IRCCS - Istituto Oncologico Veneto (Padova, Italy) Institut Bergonie (Bordeaux, France) Institut Curie- Hopital de Paris (PARIS CEDEX 05, France) Institut Jules Bordet (Anderlecht, Belgium) Istituto Clinico Humanitas (Rozzano, Milano, Italy) Karolinska University Hospital, location Solna (Stockholm Solna, Sweden) Klinikum Rechts der isar Der Technische Universitaet Muenchen - Klinikum Rechts Der Isar (Muenchen, Germany) Leeds Teaching Hospitals NHS Trust - St. James's University Hospital (Leeds, United Kingdom) Leiden University Medical Centre (Leiden, Netherlands) Ludwig-Maximilians-Universitaet Muenchen - Campus Grosshadern (Muenchen, Germany) Mount Sinai Hospital (Toronto, Ontario, Canada) NHS Lothian - Western General Hospital (Edinburgh, United Kingdom) Newcastle Hospitals NHS Trust - Freeman Hospital, Northern Centre For Cancer Care (Newcastle upon Tyne, United Kingdom) Nottingham University Hospitals NHS Trust - City Hospital (Nottingham, United Kingdom) Oslo University Hospital - Radiumhospitalet (Oslo, Norway) Radboud University Medical Center Nijmegen (Nijmegen, Netherlands) Royal Marsden Hospital - Chelsea, London (London, United Kingdom) Sheffield Teaching Hospitals NHS Foundation Trust - Weston Park Hospital (Sheffield, United Kingdom) The Christie NHS Foundation Trust (Manchester, United Kingdom) The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis (Amsterdam, Netherlands) U.Z. Leuven - Campus Gasthuisberg (Leuven, Belgium) UHB-Queen Elisabeth Medical Centre (Birmingham, United Kingdom) UniversitaetsMedizin Mannheim (Mannheim, Germany) Universitaetsklinikum Koeln (Koeln, Germany) University College Hospital (London, United Kingdom) University Hospitals Bristol NHS Foundation Trust - Bristol Haematology And Oncology Centre (Bristol, United Kingdom) University Medical Center Groningen (Groningen, Netherlands)
Centers to be activated	CHU de Toulouse - Institut Claudius Regaud - IUCT oncopole (TOULOUSE CEDEX 9, France)
Protocol summary	http://clinicaltrials.gov/ct/show/NCT01344018
NCT number	NCT01344018
Financial Support	Academic Fund EORTC Group External Grant